Presentations Medicenna Therapeutics Corp. – Corporate Presentation March 2026 Medicenna Therapeutics Corp. – Corporate Presentation February 2026 Medicenna Therapeutics -- Corporate Presentation January 2026 MDNA11 Clinical Data Update & KOL Webinar Past Events September 16, 2020 at 10:30 AM EDT H.C. Wainwright 22nd Annual Global Investment Conference 2020 (virtual) Go to June 18, 2020 at 1:40 PM EDT Raymond James Human Healthcare Innovation Conference Go to June 9 - June 12, 2020 Spring Virtual Investor Summit (Virtual) Go to May 29 - May 31, 2020 MDNA55 survival in recurrent glioblastoma ("rGBM") patients expressing the interleukin-4 receptor ("IL4R") as compared to a matched synthetic control Go to May 29 - May 31, 2020 In vitro and in vivo characteristics of MDNA11: A long-acting 'Beta-only' IL-2 Superkine in syngeneic mice tumor models and non-human primates Go to March 26 - March 27, 2020 6th Annual Immuno-Oncology Innovation Forum (Virtual) Go to Pagination First page « first Previous page ‹ previous … Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Current page 15 Page 16 Next page next › Last page last »
September 16, 2020 at 10:30 AM EDT H.C. Wainwright 22nd Annual Global Investment Conference 2020 (virtual) Go to
May 29 - May 31, 2020 MDNA55 survival in recurrent glioblastoma ("rGBM") patients expressing the interleukin-4 receptor ("IL4R") as compared to a matched synthetic control Go to
May 29 - May 31, 2020 In vitro and in vivo characteristics of MDNA11: A long-acting 'Beta-only' IL-2 Superkine in syngeneic mice tumor models and non-human primates Go to
